Comparison of outcomes with elranatamab and real world treatments in the UK for triple class exposed relapsed and refractory multiple myeloma by Carmen Tsang, Joseph E. O’Reilly, Lewis Carpenter, Charles Duffield, Filipa Tunaru, Jamie Wallis, Alycia Perkins, Thomas Price, Sam Wood, Karthik Ramasamy

Get full text